meta-analysis of 30 randomized trials of treatments for adult major depression, Cuijpers et al 1 concluded that pharmacotherapy was more efficacious than psychotherapy for dysthymia. A meta-analysis by Imel et al 2 reached similar conclusions, but another by Pinquart et al 3 on later-life depression reported that pharmacotherapy was less effective than psychotherapy for dysthymia. The strength of conclusions derived from meta-analyses stems directly from the quality and quantity of data available to address the research question. Unfortunately, the scientific literature on comparative trials of psychotherapy for dysthymia is not well enough established at this point to answer this question.
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The last trial 9 included in the meta-analysis was the only one of cognitive-behavioral therapy (CBT) for dysthymia. Although the sample size was small and differences were not significant, retention in the CBT condition was 91% versus only 67% in the medication condition. If nonresponders are more likely than responders to drop out, the higher discontinuation rate in the medication arm may have made this condition appear more efficacious than it actually was.
Previous reports suggest that psychotherapy for dysthymia may require a greater number of sessions than typically used in acute depression treatment and specific adaptation for chronic illness. 10 Adapted CBT appears effective: in another large trial, 11 the cognitive-behavioral analysis system of psychotherapy for chronic depression was found to be as effective as medication alone for patients with co-occurring major depression and dysthymia.
A more appropriate interpretation of the evidence to date is that comprehensive CBT adapted for chronic depression is a promising treatment for dysthymia and that brief psychotherapy or IPT specifically may be less effective than antidepressants during acute treatment. Further research is needed to determine the efficacy of different types of psychotherapy versus antidepressants for dysthymia, especially for longer-term outcomes. Until such trials are conducted, meta-analyses of these data are premature, and definitive conclusions about the efficacy of "psychotherapy" for dysthymia appear unwarranted.
